↓ Skip to main content

Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations

Overview of attention for article published in SpringerPlus, February 2015
Altmetric Badge

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
23 Mendeley